Phospho-PRAS40(Thr246) predicts trastuzumab response in patients with HER2-positive metastatic breast cancer.
about
Phospho-PRAS40(Thr246) predicts trastuzumab response in patients with HER2-positive metastatic breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phospho-PRAS40
@nl
Phospho-PRAS40(Thr246) predict ...... tive metastatic breast cancer.
@en
type
label
Phospho-PRAS40
@nl
Phospho-PRAS40(Thr246) predict ...... tive metastatic breast cancer.
@en
prefLabel
Phospho-PRAS40
@nl
Phospho-PRAS40(Thr246) predict ...... tive metastatic breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Phospho-PRAS40(Thr246) predict ...... tive metastatic breast cancer.
@en
P2093
Hongqiang Chen
Hongyan Wu
Mingwen Jiao
Rongzhan Fu
Yulong Wang
P2860
P304
P356
10.3892/OL.2014.2744
P577
2014-11-28T00:00:00Z